Model-informed development of bacteriophage therapy: bridging in vitro and in vivo efficacy against multidrug-resistant Pseudomonas aeruginosa.

Saved in:
Bibliographic Details
Title: Model-informed development of bacteriophage therapy: bridging in vitro and in vivo efficacy against multidrug-resistant Pseudomonas aeruginosa.
Authors: Cha JS; Department of Pharmacology, Yonsei University, Seodaemun-gu, Seoul, Republic of Korea.; Department of Pharmacology, Graduate School of Medical Science, Brain Korea 21 Project, Yonsei University College of Medicine, Seodaemun-gu, Seoul, Republic of Korea., Kim K; Microbiotix Co., Ltd, Seoul, Republic of Korea., You HJ; Microbiotix Co., Ltd, Seoul, Republic of Korea., Kim D; Microbiotix Co., Ltd, Seoul, Republic of Korea., Park HH; Microbiotix Co., Ltd, Seoul, Republic of Korea., Heo S; Microbiotix Co., Ltd, Seoul, Republic of Korea., Kim CO; Department of Clinical Pharmacology, Severance Hospital, Yonsei University Health System, Seoul, Republic of Korea., Jin BH; Department of Clinical Pharmacology, Severance Hospital, Yonsei University Health System, Seoul, Republic of Korea., Yong D; Microbiotix Co., Ltd, Seoul, Republic of Korea.; Department of Laboratory Medicine and Research Institute of Bacterial Resistance, Yonsei University College of Medicine, Seoul, Republic of Korea., Chae D; Department of Pharmacology, Yonsei University, Seodaemun-gu, Seoul, Republic of Korea.; Microbiotix Co., Ltd, Seoul, Republic of Korea.
Source: MSystems [mSystems] 2025 Dec 17; Vol. 10 (12), pp. e0138425. Date of Electronic Publication: 2025 Nov 13.
Publication Type: Journal Article
Journal Info: Publisher: American Society for Microbiology Country of Publication: United States NLM ID: 101680636 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2379-5077 (Electronic) Linking ISSN: 23795077 NLM ISO Abbreviation: mSystems Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2379-5077
DOI:10.1128/msystems.01384-25